Drug Database
Back to search

Poland· PL-100440316

Roxan

A rivaroxaban product containing rivaroxabanum, registered in Poland by Adamed Pharma S.A..

ATC B01AX06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRoxanATCB01AX06REGISTER NO.PL-100440316PACKS LISTED9CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about rivaroxabanumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

URPL (Poland)
Active substance
Rivaroxabanum
Manufacturer
Adamed Pharma S.A.
Country
Poland (PL)
ATC code
B01AX06
ATC class
Rivaroxaban
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 9

  • gtin
    05900411006514
  • gtin
    05900411006538
  • gtin
    05900411006545
  • gtin
    05900411006460
  • gtin
    05900411006477
  • gtin
    05900411006484
  • gtin
    05900411006491
  • gtin
    05900411006507
  • gtin
    05900411006521

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

349 interactions on record for rivaroxaban.

Graded by severity as the source publishes them — 134 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check rivaroxaban against other medicinesHow interaction checks work

Rivaroxaban · interactions on record

349 records

  • 134 severe
  • 213 moderate
  • 2 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rivaroxaban in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rivaroxaban products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Rivahib, Rivaroksaban Grindeks
  • Belgium · Rivaroxaban, Rivaroxaban  Eg
  • Bulgaria · Xaboplax Sandoz Pharmaceuticals D.D, Виатрикс
  • Cyprus · Enkia, Naxat
  • Czechia · Axaltra, Bevimlar
  • Germany · Elmardya, Rivadia
  • Denmark · Blomensy, Dovequa
  • Estonia · Enkia, Kardatuxan
  • Spain · Blomensy, Elmardya
  • Finland · Blomensy, Dovequa
  • France · Elmardya, Rivaroxaban Almus
  • United Kingdom (Northern Ireland) · Rivaroxaban, Rivaroxaban Abdi
  • Greece · Blomensy, Cinstel
  • Croatia · Aban, Bevimlar
  • Hungary · Dovequa, Evoxyr
  • Ireland · Rivaroxaban Ascend, Rivaroxaban Azure
  • Iceland · Agublon, Barsovi
  • Italy · Ellebax, Indifaxa
  • Liechtenstein · Rivaroxaban Accord, Rivaroxaban Viatris
  • Lithuania · Enkia, Kardatuxan
  • Luxembourg · Rivaroxaban Eg, Rivaroxaban Eg (Eurogenerics) Nv
  • Latvia · Kardatuxan, Mibrex
  • Malta · Enkia, Naxat
  • Netherlands · Blomensy, Rivaroksaban Grindeks
  • Norway · Dovequa, Rivaroxaban Accord
  • Portugal · Closderive, Enkia
  • Romania · Closderive, Enkia
  • Sweden · Bevimlar, Blomensy
  • Slovenia · Dovequa, Ribas
  • Slovakia · Assubex, Bevimlar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdc7bd88-f84e-4a11-b14e-b3adfbf08d14
GET /v1/drugs/cdc7bd88-f84e-4a11-b14e-b3adfbf08d14?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05900411006460 ¦ Rp ¦ 137487\n10 tabl.\n05900411006477 ¦ Rp ¦ 137488\n14 tabl.\n05900411006484 ¦ Rp ¦ 137489\n28 tabl.\n05900411006491 ¦ Rp ¦ 137490\n30 tabl.\n05900411006507 ¦ Rp ¦ 137491\n42 tabl.\n05900411006514 ¦ Rp ¦ 137492\n56 tabl.\n05900411006521 ¦ Rp ¦ 137493\n90 tabl.\n05900411006538 ¦ Rp ¦ 137494\n98 tabl.\n05900411006545 ¦ Rp ¦ 137495\n100 tabl.",
  "substance": "Rivaroxabanum 20 mg",
  "common_name": "Rivaroxabanum",
  "pl_product_id": "100440316",
  "pozwolenie_nr": "26428",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about rivaroxaban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console